ZK-283197
id:
zk-283197-315-16773675
title:
ZK-283197
text:
ZK-283197 is a selective and orally active ERβ agonist which was under development by Bayer Healthcare AG for the treatment of vasomotor symptoms. It reached phase II clinical trials prior to the discontinuation of its development. Its development was terminated in 2014.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/ZK-283197
date created:
date modified:
2023-01-24T16:39:33Z
main entity:
{"identifier":"Q55638180","url":"https://www.wikidata.org/entity/Q55638180"}
image:
fields total:
13
integrity:
14